Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 7Genitourinary 4Other hematologic neoplasm 3Lymphoid 2Breast 2Sarcoma 1Gastrointestinal 1Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Brain Neoplasms 2

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Methylphenidate × Lymphoid × Clear all
NCT00576472 2017-05-30

Learning Impairments Among Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 4 Completed
469 enrolled 43 charts
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01100658 2015-03-27

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

University of Minnesota

Phase NA Terminated
1 enrolled 3 charts
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡